The endovascular aneurysm repair devices market has seen considerable growth due to a variety of factors.
• The market size for endovascular aneurysm repair devices has seen robust growth in the past few years. There will be an increase from $2.43 billion in 2024 to $2.63 billion in 2025, equating to a compound annual growth rate (CAGR) of 8.2%.
Factors such as the better results obtained from EVAR operations, enhanced accuracy and safety of the EVAR technology, favorable insurance reimbursements, positive outcomes of clinical trials, and regulatory approvals have contributed to this growth during the historical period.
The endovascular aneurysm repair devices market is expected to maintain its strong growth trajectory in upcoming years.
• Expectations are high for robust growth in the endovascular aneurysm repair devices market in the coming years. The market size is projected to reach $3.56 billion by 2029, with a compound annual growth rate (CAGR) of 7.9%.
Factors contributing to this growth include increased demand for minimally invasive procedures, innovation in device safety and efficacy, a shift from traditional surgery towards minimally invasive approaches, advancements in imaging and diagnostic methods, and better surgical outcomes. Future trends to watch include progress in stent graft technology, improved patient results and shortened recovery periods, incorporation of imaging and navigational technology in EVAR processes, creation of hybrid EVAR devices, as well as advancements in regulation and new EVAR device approvals.
The surge in demand for surgical treatments with minimal invasion is anticipated to drive the expansion of the endovascular aneurysm repair devices market. These surgical treatments involve less physical intrusion and fewer incisions using specialized equipment and techniques. Factors fueling this demand include decreased recovery duration, fewer complication risks, smaller cuts leading to less discomfort, along with enhanced precision and results. Devices for endovascular aneurysm repair, also known as EVAR, facilitate minimally invasive operations by fortifying the walls of blood vessels and rerouting the blood flow, thereby lowering aneurysm rupture chances. For example, in January 2024, Intuitive Surgical Inc., a company based in the US that makes robotic products, announced that they installed 415 da Vinci surgical systems (robotic surgical systems for minimally invasive surgery) in the last quarter of 2023. This showed a rise of 12% compared to 2022. Thus, this uptick in minimally invasive surgeries is fuelling the growth of the endovascular aneurysm repair devices market.
The endovascular aneurysm repair devices market covered in this report is segmented –
1) By Aneurysm Type: Abdominal Aortic Aneurysms (AAA), Thoracic Aortic Aneurysms (TAA), Peripheral Aneurysms
2) By Application: Endovascular Grafts, Stent-Grafts, Catheters, Delivery Systems, Imaging Systems
3) By End User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics
Subsegments:
1) By Abdominal Aortic Aneurysms (AAA): Infrarenal AAA, Juxtarenal AAA, Pararenal AAA
2) By Thoracic Aortic Aneurysms (TAA): Ascending Aortic Aneurysms, Aortic Arch Aneurysms, Descending Aortic Aneurysms
3) By Peripheral Aneurysms: Femoral Aneurysms, Popliteal Aneurysms, Iliac Aneurysms, Renal Aneurysms
Firms dominating the endovascular aneurysm repair device space are concentrating their efforts on the establishment of ground-breaking solutions, such as abdominal stent-graft systems. The aim is to achieve a greater degree of device durability, higher rates of procedural success, and simplified deployment, thus improving patient results overall. The abdominal stent-graft system is a specialized medical instrument employed in endovascular aneurysm repair (EVAR) procedures as a treatment option for abdominal aortic aneurysms (AAA). For example, in August 2024, Terumo India, an India-based medical tech entity, brought to the market the TREO Abdominal Stent-Graft System. This novel solution for addressing abdominal aortic aneurysms (AAAs) in adults with suitable anatomies incorporates a distinct three-piece construction, offering both suprarenal and infrarenal active fixation potential, bolstering effectiveness and steadiness during endovascular aneurysm repair (EVAR). Outlined features include the ability for in situ limb adjustment for meticulous deployment, improved sealing at the proximal end to avert leaks, and the inclusion of superior lock stent technology to reduce risks associated with migration.
Major companies operating in the endovascular aneurysm repair devices market are include:
• Cardinal Health Inc.
• Johnson & Johnson
• Abbott Laboratories
• Medtronic Plc
• Royal Philips
• Boston Scientific
• Terumo Corporation
• Biotronik
• L. Gore & Associates Inc.
• AorTech International
• Teleflex Incorporated
• Getinge AB
• Cook Medical Group
• Lombard Medical Technologies plc
• Merit Medical Systems
• Penumbra Inc.
• Volcano Corporation
• Endologix Inc.
• Scranton Gillette Communications
• Medico S.p.A
North America was the largest region in the endovascular aneurysm repair devices market in 2024. The regions covered in the endovascular aneurysm repair devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.